|4May 22, 4:58 PM ET

Arno Andrew 4

4 · Oncocyte Corp · Filed May 22, 2024

Insider Transaction Report

Form 4
Period: 2024-05-20
Arno Andrew
Director
Transactions
  • Award

    Option to Purchase Common Stock

    2024-05-20+20,00020,000 total
    Exercise: $2.76Exp: 2034-05-20Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary